Translating single nucleotide polymorphism tests from clinical research to clinical practice

Area of Science:

• Pharmacogenomics
• Clinical Pharmacology
• Biotechnology

Background:

• Pharmacogenomics research identifies genetic markers, such as single nucleotide polymorphisms (SNPs), that predict drug efficacy and toxicity.
• Publication of these associations marks an endpoint in research but is the starting point for clinical translation.

Purpose of the Study:

• To outline the multifaceted process of translating pharmacogenomic discoveries from research findings to validated clinical diagnostic assays.
• To highlight the critical steps and challenges involved in moving genetic associations into routine clinical practice.

Main Methods:

• Review of the translational pathway for pharmacogenomic discoveries.
• Identification of key stakeholders and issues in clinical implementation.

Main Results:

• The transition from research publication to a widely available pharmacodiagnostic assay is a complex, multi-stage process.
• Successful translation requires addressing scientific, clinical, technological, commercial, regulatory, and educational considerations.

Conclusions:

• Validation and implementation of pharmacogenomic findings into clinical practice require a comprehensive, multidisciplinary approach.
• Bridging the gap between research and clinical application is essential for personalized medicine advancements.